** NAFDAC joins the Federal Ministry of Health and Social Welfare, nutrition partners, and the rest of the world in celebrating World Breastfeeding Week 2024 from 1st to 7th August. The theme for this year is ' Closing the gap: Breastfeeding Support for All'. Let us all join hands to protect, promote, and support breastfeeding. Happy World Breastfeeding Week! ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6 ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6 ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6
** NAFDAC joins the Federal Ministry of Health and Social Welfare, nutrition partners, and the rest of the world in celebrating World Breastfeeding Week 2024 from 1st to 7th August. The theme for this year is ' Closing the gap: Breastfeeding Support for All'. Let us all join hands to protect, promote, and support breastfeeding. Happy World Breastfeeding Week! ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6 ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6 ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6
  1. Home
  2. »
  3. Recalls and Alerts
  4. »
  5. Public Alert No. 019/2024 – Alert on falsification of a batch of Giga-S Injection 

Public Alert No. 019/2024 – Alert on falsification of a batch of Giga-S Injection 

The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of a falsified batch of Giga-S Injection identified in Aba, Abia State.

The falsified batch was purchased from a renowned store located at Araria Market in Aba, Abia State.

GigaS injection Ceftriaxone + Sulbactam Inj.1.5g IM/IV is indicated for the treatment of severe infections due to susceptible organisms including septicemia; pneumonia; and meningitis.

Product Details

The details of the original batch are as follows: –

Product Name

Giga-S Injection

Genuine Manufacturer

Inject Care Parenteral Pvt, Ltd. Plot No. 130, Silvassa Road, GIDC, Vapi- 396195 Gujarat, India.

Batch number

1C21163006

Expiry date

Sept. 2023

Date of manufacture

Oct. 2021

Product photo of Genuine (Expired Giga-S Injection)

 

The details of the Falsified are as follows:

Product Name

Giga-S Injection

Stated Manufacturer

Inject Care Parenterals Pvt, Ltd. Plot No. 130, Silvassa Road, GIDC, Vapi- 396195 Gujarat, India.

Batch number

1C21163006

Expiry date

Sept. 2026

Date of manufacture

Oct. 2023

Photo of the Falsified Giga-S Injection

Although this falsified batch product was identified in Abia state, it may likely have been distributed to other parts of the country through informal markets. Consequently, it is important to detect and remove it from circulation to prevent harm to patients.

NAFDAC, implores importers, distributors, retailers, and healthcare providers to always exercise caution and vigilance within the supply chain to avoid the importation, distribution, sale, and administration or use of falsified or substandard medicinal products. All medical products must be obtained from authorized/licensed suppliers. The products’ authenticity and physical condition should be carefully checked. 

Members of the public in possession of the above product are advised to discontinue sale or use and submit stock to the nearest NAFDAC office.

If you have this counterfeit product, please DO NOT use it. If you, or anyone you know, have used this product, or suffered any adverse reaction/event after use, you are advised to seek immediate medical advice from a qualified healthcare professional.

Healthcare professionals and consumers are advised to report any suspicious substandard and falsified medicines to the nearest NAFDAC office, NAFDAC on

0800-162-3322 or via email: sf.alert@nafdac.gov.ng

Similarly, healthcare professionals and patients are also encouraged to report adverse events or side effects related to the use of medicinal products to the nearest NAFDAC office, or through the use of the E-reporting platforms available on the NAFDAC website www.nafdac.gov.ng or via the Med- safety application available for download on android and IOS stores or via e-mail on pharmacovigilance@nafdac.gov.ng

Furthermore, note that this notice will be uploaded to the WHO Global Surveillance and Monitoring System (GSMS).

NAFDAC……….Customer-focused, Agency-minded!!!

Was this helpful?

Yes
No
Thanks for your feedback!

More Actions